An annual injection to prevent HIV infection is closer to becoming reality after the first stage of a drug trial showed ...
To reduce care disparities and prevent them from exacerbating among people living with HIV who have long COVID, education and ...
The Canadian Press on MSN1h
'My heart dropped': Potential HIV, hepatitis exposure at gynecology clinic has patients worriedKarin Martin couldn't sleep last Sunday night after reading a letter from Toronto Public Health that drowned her with worry.
Research on the presence of thyroid abnormalities in HIV showed that patients with HIV are at risk for developing a variety of thyroid disorders.
Offering mailed self-testing for HIV encouraged patients to test themselves for HIV but require methods of improving ...
Without public health surveillance, officials trying to tackle outbreaks, identify threats and evaluate treatments are working ‘in the darkness of ignorance.’ ...
In 2024, technology stocks involved in artificial intelligence (AI) led the Nasdaq-100 index higher, while healthcare stocks ...
NanoViricides, Inc. (the “Company”)(NYSE American:NNVC), a clinical-stage global leader developing revolutionary broad-spectrum antiviral drugs that the viruses cannot escape, declared today that its ...
An effective HIV-1 vaccine must therefore elicit antibodies that can neutralize many variants of the virus. While broadly neutralizing antibodies (bnAbs) have been isolated from HIV-1 infected ...
Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...
Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...
MONDAY, March 10, 2025 (HealthDay News) -- A common vaginal infection that affects nearly 1 in 3 women worldwide should be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results